open access

Vol 80, No 9 (2009)
ARTICLES
Get Citation

Expression of caspase-3, Bax nad Bcl-2 in placentas from pregnancies complicated by treated and non-treated fetal growth restriction

Agnieszka nawrocka-Kunecka, Urszula Kowalska-Koprek, Anita Szczerba, Agata Karowicz-Bilińska, Grzegorz Bartosz
Ginekol Pol 2009;80(9).

open access

Vol 80, No 9 (2009)
ARTICLES

Abstract

Abstract Background: Fetal growth restriction (FGR) is the reason of high prematurity rate and its later complications. Restriction of utero-placental circulation, which could be changed by IURG treatment, plays the main role in FGR. The results of changes in apoptosis-related genes expression due to FGR treatment may help further in the prevention and treatment of FGR. Material and methods: Caspase-3, Bax and Bcl-2 expressions in normal pregnancies and those complicated by treated and untreated FGR have been compared. The study was conducted in 2005-2006 at the High-Risk Pregnancy Unit of Medical University in Łódź and Kopernik Hospital in Łódź. Caspase-3, Bax and Bcl-2 expressions were assessed by immunohistochemical method. Bcl-2 was assessed in the trophoblast, Bax and caspase-3 in the decidua and the trophoblast. Results: The mean value of Bcl-2 in the trophoblast was 58.8±12.7 in the FGR-untreated group, 37.0±0.5 in the FGR-treated group and 65.7±6.9 in the control group. In the FGR-untreated group the mean value of Bax expression was 60.6±10.7 in the trophoblast and 32.0±7.3 in the decidua. In the FGR-treated group the mean value of Bax expression was 42.2±12.2 in the trophoblast and 20.9±6.4 in the decidua. In the control group the mean value of Bax expression was 13.6±2.2 in the trophoblast and 6.6±6.8 in the decidua. In the FGR-untreated group the mean value of Cpp-32 expression was 40.1±9.1 in the trophoblast and 42.6±.12.5 in the decidua. In the FGR-treated group the mean value of Cpp-32 expression was 21.3±6.8 in the trophoblast and 23.7±5.1 in the decidua. In the control group the mean value of Cpp-32 expression was 13,6±6,3 in trophoblast and 11.6±5.3 in the decidua. Conclusions: Increased expression of pro-apoptotic proteins in the placenta might be one of the reasons for FGR development. The treatment used in the FGR group decreased the process of apoptosis.

Abstract

Abstract Background: Fetal growth restriction (FGR) is the reason of high prematurity rate and its later complications. Restriction of utero-placental circulation, which could be changed by IURG treatment, plays the main role in FGR. The results of changes in apoptosis-related genes expression due to FGR treatment may help further in the prevention and treatment of FGR. Material and methods: Caspase-3, Bax and Bcl-2 expressions in normal pregnancies and those complicated by treated and untreated FGR have been compared. The study was conducted in 2005-2006 at the High-Risk Pregnancy Unit of Medical University in Łódź and Kopernik Hospital in Łódź. Caspase-3, Bax and Bcl-2 expressions were assessed by immunohistochemical method. Bcl-2 was assessed in the trophoblast, Bax and caspase-3 in the decidua and the trophoblast. Results: The mean value of Bcl-2 in the trophoblast was 58.8±12.7 in the FGR-untreated group, 37.0±0.5 in the FGR-treated group and 65.7±6.9 in the control group. In the FGR-untreated group the mean value of Bax expression was 60.6±10.7 in the trophoblast and 32.0±7.3 in the decidua. In the FGR-treated group the mean value of Bax expression was 42.2±12.2 in the trophoblast and 20.9±6.4 in the decidua. In the control group the mean value of Bax expression was 13.6±2.2 in the trophoblast and 6.6±6.8 in the decidua. In the FGR-untreated group the mean value of Cpp-32 expression was 40.1±9.1 in the trophoblast and 42.6±.12.5 in the decidua. In the FGR-treated group the mean value of Cpp-32 expression was 21.3±6.8 in the trophoblast and 23.7±5.1 in the decidua. In the control group the mean value of Cpp-32 expression was 13,6±6,3 in trophoblast and 11.6±5.3 in the decidua. Conclusions: Increased expression of pro-apoptotic proteins in the placenta might be one of the reasons for FGR development. The treatment used in the FGR group decreased the process of apoptosis.
Get Citation

Keywords

apoptosis, caspase-3, BAX, Bcl-2, Fetal Growth Retardation, Placenta, IUGR treatment

About this article
Title

Expression of caspase-3, Bax nad Bcl-2 in placentas from pregnancies complicated by treated and non-treated fetal growth restriction

Journal

Ginekologia Polska

Issue

Vol 80, No 9 (2009)

Bibliographic record

Ginekol Pol 2009;80(9).

Keywords

apoptosis
caspase-3
BAX
Bcl-2
Fetal Growth Retardation
Placenta
IUGR treatment

Authors

Agnieszka nawrocka-Kunecka
Urszula Kowalska-Koprek
Anita Szczerba
Agata Karowicz-Bilińska
Grzegorz Bartosz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl